1199PMG1124, a novel CEACAM1-targeted monoclonal antibody,...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1199PMG1124, a novel CEACAM1-targeted monoclonal antibody, has therapeutic potential as a combination partner of PD-1 inhibitors in NSCLC patients

Lee, E H, Lee, J, Hur, M, Park, H-Y, Yum, H I, Nam, H, Oh, M-Y, Choi, H, Kim, J, Cho, B C, Lim, Y, Won, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz253.025
Date:
October, 2019
File:
PDF, 73 KB
2019
Conversion to is in progress
Conversion to is failed